BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23475064)

  • 1. The power of VEGF (vascular endothelial growth factor) family molecules.
    Thomas JL; Eichmann A
    Cell Mol Life Sci; 2013 May; 70(10):1673-4. PubMed ID: 23475064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factors and receptors: anti-angiogenic therapy in the treatment of cancer.
    Tugues S; Koch S; Gualandi L; Li X; Claesson-Welsh L
    Mol Aspects Med; 2011 Apr; 32(2):88-111. PubMed ID: 21565214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between VEGFR and Notch signaling pathways in endothelial and neural cells.
    Thomas JL; Baker K; Han J; Calvo C; Nurmi H; Eichmann AC; Alitalo K
    Cell Mol Life Sci; 2013 May; 70(10):1779-92. PubMed ID: 23479133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The direct effects of anti-vascular endothelial growth factor therapy on tumor cells.
    Moser C; Lang SA; Stoeltzing O
    Clin Colorectal Cancer; 2007 Jul; 6(8):564-71. PubMed ID: 17681102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular Endothelial Growth Factor Receptors [VEGFR] as Target in Breast Cancer Treatment: Current Status in Preclinical and Clinical Studies and Future Directions.
    Malekan M; Ebrahimzadeh MA
    Curr Top Med Chem; 2022; 22(11):891-920. PubMed ID: 35260067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factors, angiogenesis, and survival in human ileal enterochromaffin cell carcinoids.
    Besig S; Voland P; Baur DM; Perren A; Prinz C
    Neuroendocrinology; 2009; 90(4):402-15. PubMed ID: 19816005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
    Brychtova S; Bezdekova M; Brychta T; Tichy M
    Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorimetric immunoassays for the screening and specificity evaluation of molecules disturbing VEGFs/VEGFRs interactions.
    Trapiella-Alfonso L; Broussy S; Liu WQ; Vidal M; Lecarpentier E; Tsatsaris V; Gagey-Eilstein N
    Anal Biochem; 2018 Mar; 544():114-120. PubMed ID: 29284120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis.
    Smith GA; Fearnley GW; Tomlinson DC; Harrison MA; Ponnambalam S
    Biosci Rep; 2015 Aug; 35(5):. PubMed ID: 26285805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factors and angiogenesis in eye disease.
    Witmer AN; Vrensen GF; Van Noorden CJ; Schlingemann RO
    Prog Retin Eye Res; 2003 Jan; 22(1):1-29. PubMed ID: 12597922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discovery of the fundamental role of VEGF in the development of the vascular system.
    Ribatti D
    Mech Dev; 2019 Dec; 160():103579. PubMed ID: 31644946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF receptor signalling - in control of vascular function.
    Olsson AK; Dimberg A; Kreuger J; Claesson-Welsh L
    Nat Rev Mol Cell Biol; 2006 May; 7(5):359-71. PubMed ID: 16633338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGFs, receptors and angiogenesis.
    Veikkola T; Alitalo K
    Semin Cancer Biol; 1999 Jun; 9(3):211-20. PubMed ID: 10343072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.
    Lohela M; Bry M; Tammela T; Alitalo K
    Curr Opin Cell Biol; 2009 Apr; 21(2):154-65. PubMed ID: 19230644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of elevation of vascular endothelial growth factor family expression in patients with non-small cell lung cancer: an updated meta-analysis.
    Zheng CL; Qiu C; Shen MX; Qu X; Zhang TH; Zhang JH; Du JJ
    Asian Pac J Cancer Prev; 2015; 16(5):1881-95. PubMed ID: 25773840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
    Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [VEGF and its receptors as therapeutic target in cancer therapy].
    Gisterek I; Kornafel J
    Przegl Lek; 2006; 63(3):155-7. PubMed ID: 16967703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Overview of VEGF-Mediated Signal Transduction.
    Evans I
    Methods Mol Biol; 2015; 1332():91-120. PubMed ID: 26285748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular Endothelial Growth Factor Biology and Its Potential as a Therapeutic Target in Rheumatic Diseases.
    Le THV; Kwon SM
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
    Ljungberg BJ; Jacobsen J; Rudolfsson SH; Lindh G; Grankvist K; Rasmuson T
    BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.